February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 9, 2018 by CDR Blog and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, independent pharmacy owners, Medicare Part D, National Community Pharmacists Association, NCPA, S. 413 / H.R. 1038
CDR Blog
Suffice it to say, community pharmacies are getting squeezed by retroactive DIR fees. That’s what the results of a survey from the National Community Pharmacists Association said. NCPA reported Friday that, because of retroactive direct and indirect remuneration fees, 84% of independent pharmacy owners polled said they don’t know what their final reimbursement will be at
April 22, 2017 by Chain Drug Review
DIR fees, direct and indirect remuneration fees, H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, National Community Pharmacists Association, NCPA, retroactive pharmacy DIRs, S. 413
2017, Issue 04-24-2017, Issues, News
ALEXANDRIA, Va. — A group 118 health care stakeholders, including chain drug retailers, have called on Congress to crack down on direct and indirect remuneration (DIR) fees in Medicare Part D. Mobilized by the National Community Pharmacists Association (NCPA), the broad coalition sent letters to the Senate and House of Representatives to voice their support
March 29, 2017 by Chain Drug Review
DIR fees, direct and indirect remuneration fees, H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, National Community Pharmacists Association, NCPA, retroactive pharmacy DIRs, S. 413
Featured Articles, Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — Chain drug retailers were among 118 health care stakeholders calling on Congress this week to crack down on direct and indirect remuneration fees in Medicare Part D. Marshaled by the National Community Pharmacists Association, the broad coalition — also including independent pharmacies, pharmacy trade groups, drug distributors, pharmacy buying groups, supermarket retailers,
September 27, 2016 by Chain Drug Review
DIR fees, direct and indirect remuneration fees, H.R. 5951, Medicare Part D, National Community Pharmacists Association, NCPA, S. 3308
Featured Articles, Leading Headlines, Retail News
ALEXANDRIA, Va. — A group of 99 pharmacy retailers, suppliers and organizations applauded House and Senate lawmakers for introducing legislation to clamp down on retroactive direct and indirect remuneration fees imposed by pharmacy benefit managers in Medicare Part D. The National Community Pharmacists Association said the pharmacy stakeholders on Monday wrote letters to the House
August 12, 2016 by CDR Blog and Chain Drug Review
Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, National Community Pharmacists Association, NCPA, Ralph Abraham, Seth Moulton, William Keating
CDR Blog
Persistence is paying off for the National Community Pharmacists Association in its advocacy for more transparency with DIR fees. In a posting in its “The Dose” blog this week, NCPA noted that it continues to build congressional support in getting the Centers for Medicare & Medicaid Services (CMS) to finalize its guidance on direct and